category,datetime,headline,id,image,related,source,summary,url
company,1769444431,A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Weakness,138263749,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DGX,Yahoo,"Quest Diagnostics stock snapshot after recent performance Quest Diagnostics (DGX) has been on investorsâ€™ radars after a mixed stretch, with the share price showing a 0.6% decline over the past day and a 4.5% decline over the past week, alongside positive longer term returns. See our latest analysis for Quest Diagnostics. Viewed over a longer span, the recent 1 day and 7 day share price declines sit alongside a 1 month share price return of 2.9% and a 1 year total shareholder return of 15.3%...",https://finnhub.io/api/news?id=bd832480f609c966b31f07a037b5e0884689b2f4be4c4b46c1ac135a7202b081
company,1769438400,How TEM Is Capitalizing on AI-Driven Pathology Market Growth,138263745,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,DGX,Yahoo,Tempus AI boosts AI pathology reach by acquiring Paige and launching Paige Predict to deliver biomarker insights across 16 cancer types.,https://finnhub.io/api/news?id=535ba86c77fb58b9666e7b673fe39a7e52e5db60c8968c30e411f397dd92b09c
company,1769419901,Guardant Health: Look For Explosive Revenue Growth Ahead,138261573,,DGX,SeekingAlpha,,https://finnhub.io/api/news?id=7899be8b188435bbb86a74c1713ed92da5f8e95ad28af031fefc8673f80f6bc6
